title: Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma.
authors.affiliation: Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison 53706, USA.
authors.forename: W C
authors.initials: WC
authors.lastname: Kisseberth
authors.forename: E G
authors.initials: EG
authors.lastname: MacEwen
authors.forename: S C
authors.initials: SC
authors.lastname: Helfand
authors.forename: D M
authors.initials: DM
authors.lastname: Vail
authors.forename: C L
authors.initials: CL
authors.lastname: London
authors.forename: E
authors.initials: E
authors.lastname: Keller
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004317:Doxorubicin / Q000008:administration & dosage*; D004337:Drug Carriers; D005260:Female; D008081:Liposomes; D009101:Multiple Myeloma / Q000188:drug therapy / Q000662:veterinary*; D012074:Remission Induction
chemical_list: D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D008081:Liposomes; D004317:Doxorubicin